CD34 and leukemia: CSCs were primarily discovered in leukemia as characterized by the CD34+/CD38− phenotype by John and Bonnet in 1997 [15] and were subsequently identified in solid tumors such as colon, breast, ovarian, pancreatic, hepatocellular carcinoma and thyroid cancer [16].